Fig. 4From: N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinomaA Box diagram showing the immune scores in the high- and low-SNRPC groups. B Box diagram showing the stromal scores in the high- and low-SNRPC groups. C Box diagram demonstrating the ESTIMATE scores in the high- and low-SNRPC groups. D Box diagram demonstrating the tumor purity in the high- and low-SNRPC groupsBack to article page